Prothena | PRTA - Текущие обязательства





Текущие обязательства Изменить Дата
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Akebia Therapeutics USD 173.88M 10.95M 2026-03
ALKERMES USD 662.09M 62.59M 2026-06
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Amgen USD 24.96B 534M 2026-03
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Immunic USD 38.36M 7.74M 2026-03
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 717M 66M 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Prothena USD 32.52M 8.33M 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03